Research Focus Teams
Rare Disease
Research Interests
Structure, function & regulation of photoreceptor proteins; Design and development of reagents for the purification and characterization of membrane proteins; Molecular and cellular mechanisms underlying retinal degenerative diseases including Stargardt disease, retinitis pigmentosa and X-linked retinoschisis; drug discovery and gene-based therapy for retinal degenerative diseases; Molecular characterization of lipid flippases with emphasis on ABC transporters and P4-ATPases; Molecular characterization of protein-protein interactions responsible for the structure and function of rod photoreceptor cells->
Departments
Biochemistry & Molecular Biology
Bio
Dr. Robert Molday is a Professor in the Department of Biochemistry & Molecular Biology at UBC. He obtained a BSc Honors Degree in Chemistry at the University of Pennsylvania (Univ. of Penn.), a MSc in Chemistry at Georgetown University, and a Ph.D. degree in Biophysical Chemistry from the Univ. of Penn. School of Medicine. After postdoctoral research training at the California Institute of Technology, he was appointed to the faculty at the UBC.
Dr. Molday's research has been primarily directed toward the molecular and cellular characterization of key membrane proteins involved in vision and inherited retinal degenerative diseases that cause a severe loss in vision. His laboratory has been contributed to the identification, localization, purification and structural and functional characterization of peripherin-2-rom-1 complex, the cyclic GMP-gated channel, rhodopsin, the sodium/calcium-potassium exchanger (NCKX1), the ABC transporter ABCA4, guanylate cyclase (RetGC1), RD3, mammalian P4-ATPases phospholipid flippases, and retinoschisin. His studies have led to new insight into phototransduction, the visual cycle, membrane lipid asymmetry, and the structure and renewal of rod photoreceptor membranes. His research has also led to insights into the molecular mechanisms underlying various inherited retinal diseases including Stargardt macular dystrophy linked to ABCA4, retinitis pigmentosa associated with rhodopsin and peripherin-2, X-linked retinoschisis linked to retinochisin, and Lebers Congenital Amaurosis-12 associated with RD3, and the development and application of gene therapy as a promising treatment for several of these diseases. Dr. Molday is internationally recognized for the design, development and application of novel reagents and techniques that have broad application in biomedical research. These include magnetic and polymer microspheres for the separation of specific cells and cellular components, and the generation and characterization of monoclonal antibodies for the purification, localization, and structural analysis of complex membrane proteins.
Dr. Molday has received numerous honours for his scientific achievements. He is a Fellow of the Royal Society of Canada, a former Canada Research Chair Tier I in Vision and Macular Degeneration, and founding Director of the Centre for Macular Research at UBC. He has received numerous international awards including the Friedenwald Award from the Association for Research in Vision and Ophthalmology (ARVO), the Ludwig von Sallmann Prize from the International Society for Eye Research (ISER), Alcon Research Award from the Alcon Institute, the CNIB Chanchlani Global Vision Award, and the Alexander von Humboldt Award. He has also received UBC awards including Jacob Biely Faculty Prize, the Bill and Marilyn Webber and UBC Faculty of Medicine Lifetime Achievement Awards. Dr. Molday holds 8 patents and serves as a consultant for several pharmaceutical and biotech companies.